In Europe around 17% of all pregnant women are RhD-negative. Since the beginning of the 1990s, these women have been receiving RhD prophylaxis in the 28th to 30th week of pregnancy in addition to the targeted postpartum administration. This prenatal Rh prophylaxis, which is usually carried out independently of the RhD status of the fetus, […]
This author has yet to write their bio.Meanwhile lets just say that we are proud sfrank contributed a whooping 8 entries.
Entries by sfrank
In a current study in collaboration with Prof. Oliver Kagan (University Hospital Tübingen) and Francesca Grati (TOMA Advanced Biomedical Assays SpA, Impact Lab Group), published in Prenatal Diagnosis in August 2020, the positive predictive value (PPV) in screening for gonosomal aneuploidies (sex chromosomal aneuploidies [SCA]) was determined.